Company Filing History:
Years Active: 2019
Title: Innovations of Hung-Li Wang in Neurodegenerative Disease Treatment
Introduction
Hung-Li Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of neurodegenerative diseases and pain management through his innovative research and patents. His work focuses on developing compounds that can be utilized in the prevention and treatment of these conditions.
Latest Patents
Hung-Li Wang holds a patent for "Compounds for use in prevention and treatment of neurodegenerative diseases and pain." This patent discloses various compounds, including N-[(3-halothien-2-yl)methyl]adenosine, N-[(4-halothien-2-yl)methyl]adenosine, and N-[(5-halothien-2-yl)methyl]adenosine. Additionally, it includes compounds such as N-[(2-bromothien-3-yl)methyl]adenosine, N-[(4-bromothien-3-yl)methyl]adenosine, N-[(5-bromothien-3-yl)methyl]adenosine, N-[(2-chlorothien-3-yl)methyl]adenosine, N-[(4-chlorothien-3-yl)methyl]adenosine, and N-[(5-chlorothien-3-yl)methyl]adenosine. The patent also outlines methods for making and using these compounds.
Career Highlights
Hung-Li Wang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has garnered attention for its potential impact on treating neurodegenerative diseases, which are a growing concern in modern medicine. With 1 patent to his name, he continues to push the boundaries of scientific research.
Collaborations
Hung-Li Wang has collaborated with esteemed colleagues such as Jim-Min Fang and Yun-Lian Lin. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the field.
Conclusion
Hung-Li Wang's contributions to the treatment of neurodegenerative diseases through his patented compounds highlight the importance of innovation in medical research. His work at Academia Sinica and collaborations with fellow researchers underscore the collaborative nature of scientific advancement.